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Chromatin remodeling enzymes: who’s on first?
Christopher J. Fry and Craig L. Peterson
A central problem in the regulation of eukaryotic gene
expression is understanding how gene-specific
transcriptional activators orchestrate the recruitment of
the myriad proteins that are required for transcription
initiation. An emerging view indicates that activators
must first target two types of chromatin remodeling
enzyme to the promoter region: an ATP-dependent
SWI/SNF-like complex and a histone acetyltransferase.
These two enzymes appear to act synergistically to
establish a local chromatin structure that is permissive
for subsequent events. Furthermore, several recent
studies indicate that the recruitment of chromatin
remodeling enzymes must follow an obligatory,
sequential order of events that is determined by either
promoter context or cell-cycle position. Here we review
recent developments concerning the role of chromatin
remodeling enzymes in gene regulation, and propose
several models to explain how different chromatin
remodeling activities can be functionally coupled.
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Introduction
The transcriptional machinery of eukaryotes faces a number
of challenges during the assembly of an active RNA poly-
merase II transcription pre-initiation complex. First and
foremost, transcription factors must gain access to a DNA
template which is folded into compact, 30–400 nM thick
chromatin fibers. Nucleosome assembly virtually elimi-
nates the ability of the general transcription factors, such
as TFIID and the RNA polymerase II holoenzyme, to inter-
act with promoter sequences, and thus one of the key
roles of gene-specific, transcriptional activators is to target
promoter regions for the unfolding or remodeling of chro-
matin structure. Chromatin remodeling is not an inherent
feature of transcriptional activators; rather, activators recruit
specialized enzymes which carry out the chromatin remod-
eling events required for subsequent pre-initiation complex
assembly. Activators also play key roles in the recruitment
of the basal transcription machinery, and thus, activators
must orchestrate interactions with a multitude of targets,
all of which are required for efficient transcription initia-
tion (Figure 1) (for a recent review, see [1]).
Two types of chromatin remodeling enzyme can be
targeted to promoters through interactions with transcrip-
tional activators. The first class of enzymes, which are
related to the 2 MDa yeast SWI/SNF complex, can
hydrolyze approximately 1000 ATP molecules per minute
and use the energy of ATP hydrolysis to disrupt
histone–DNA interactions (for a recent review, see [2]).
The second class consists of nuclear histone acetyltrans-
ferases (HATs), such as yeast Gcn5p, Esa1p/mof/Tip60,
mammalian GCN5/PCAF, and the CBP/p300 proteins (for
a recent review, see [3]). These enzymes disrupt chromatin
structure by covalently modifying, by acetylation, lysine
residues within the amino-terminal domains of the nucleo-
somal histones. Here we discuss new developments that
address the roles of these enzymes in transcription, with
special emphasis on possible mechanisms that might
explain the interdependent recruitment of HATs and
SWI/SNF-like enzymes.
Chromatin remodeling enzymes
The ATP-dependent family of remodeling enzymes
Each member of the ATP-dependent family of chromatin
remodeling enzymes contains an ATPase subunit that is
related to the SWI2/SNF2 subfamily of the DEAD/H box
superfamily of nucleic acid-stimulated ATPases [4].
Seventeen members of the SWI2/SNF2 family have been
identified in the yeast genome [5], and to date, five
of these ATPases have been purified as subunits of dis-
tinct chromatin-remodeling complexes: ySWI/SNF [6,7],
yRSC [8], INO80.com [9], ISW1 and ISW2 [10]. Addi-
tional ATP-dependent remodeling complexes that harbor
SWI2/SNF2 family members have been identified in
Drosophila (dACF [11], dNURF [12], dCHRAC [13],
Brahma [14]), human (hSWI/SNF [15], hNURD [16–18],
hRSF [19]) and frog (xMi-2 [20], xACF [21]). These ATP-
dependent chromatin-remodeling complexes have been
further divided into three groups based on whether the
sequence of the ATPase subunit is more related to yeast
SWI2 (ySWI/SNF, yRSC, Brahma, hSWI/SNF), Drosophila
ISWI (ISW1, ISW2, INO80.com, dNURF, dCHRAC,
dACF, hRSF, xACF), or human Mi-2 (hNURD, xMi-2)
(reviewed in [22]).
Role of SWI/SNF-like enzymes in control of cell
proliferation and development
Whereas many members of the ISWI-like and Mi-2-like
subgroups appear to be dedicated to transcriptional repres-
sion pathways [23–27], most SWI/SNF-like enzymes play
direct roles in the activation of transcription. In yeast,
genes that encode many of the eleven subunits of the
ySWI/SNF complex were initially identified in genetic
screens for positive regulators of transcription [28]. Subse-
quent studies demonstrated that the ySWI/SNF complex
is required for expression of a subset of highly inducible
genes — for example, HIS3, SUC2, INO1, PHO8 — and
for the functioning of a variety of transcriptional activators
[28]. In addition, genome-wide expression analyses have
shown that inactivation of ySWI/SNF leads to decreases in
steady-state transcription of around 5% of the approxi-
mately 6000 yeast genes when RNA is isolated from asyn-
chronous cell cultures [29,30]. 
In a recent study, ySWI/SNF was discovered to play a
more global role in the transcriptional activation of genes
that are expressed during mitosis [31]. In budding yeast,
approximately 300 cell-cycle-regulated genes show peak
levels of expression during mitosis, and of this set 113
genes are expressed during late anaphase/early telophase
[32,33]. Many of these genes encode cell-cycle factors
that regulate mitotic exit or subsequent cell-cycle events.
For instance, ySWI/SNF is required for the telophase
expression of the cyclin-dependent kinase (Cdk)
inhibitor, Sic1p, which contributes to the deactivation of
mitotic Cdk–cyclin B kinase activity, and loss of mitotic
Sic1p expression leads to a delay in mitotic exit [34,35].
ySWI/SNF is also required both for the mitotic expres-
sion of EGT2, which promotes cytokinesis, and the
telophase expression of CDC6, which controls the assem-
bly of pre-replication complexes for the subsequent
S phase [31,36,37]. In total, at least 25% of the genes
expressed at the end of mitosis require a functional
ySWI/SNF complex [29–31]. Interestingly, a mitotic role
for SWI/SNF-like complexes is not restricted to yeast, as
recently it was reported that SWI/SNF in the nematode
Caenorhabditis elegans is required in late mitosis for the
subsequent asymmetric division of T cells during early
development [38]. 
The Drosophila brahma complex also plays key roles in
transcriptional activation. Genetic studies have focussed
on four subunits of the 2 MDa brahma complex — brm,
(homolog of yeast Swi2p/Snf2p), moira (homolog of yeast
Swi3p), snr1 (homolog of yeast Snf5p), and osa (possible
homolog of yeast Swi1p). With the exception of snr1,
these genes were identified as members of the trithorax
group, which is required for maintenance of homeotic
gene expression [39]. Furthermore, genetic analysis of osa
mutations suggests that the brahma complex is required
for the function of the Wingless signaling pathway and the
E2F cell-cycle regulator [40,41].
Mammalian cells have at least two distinct SWI/SNF-like
complexes that share many of the same subunits, but are
R186 Current Biology Vol 10 No 5
Figure 1
Sequence-specific DNA-binding
transcriptional activator proteins regulate
eukaryotic gene expression by binding to
promoter regions of genes and recruiting
multiple coactivator proteins — the SWI/SNF-
like ATPases and histone acetyltransferases
(HATs) — in addition to components of the
general transcriptional machinery — the TAFIIs,
Mediator/SRB and RNA polymerase II
(RNAPII). Many activator proteins can interact
with and recruit a multitude of coactivators
and general transcription factors, but it is
often unclear which of these interactions are
critical and whether the order of recruitment
of these factors is important for transcriptional
activation of specific target genes. Ac,
acetylation; INR, initiator element; TATA,
TATA box motif.














distinguished by their ATPase subunits, BRG1 or BRM.
Each of these ATPases shows a high level of sequence
identity to Drosophila brm (52% identify) and yeast
Swi2p/Snf2p (33% identity), and the recombinant human
BRG1 and hBRM proteins share similar ATPase and
remodeling activities [42]. In human cells, hSWI/SNF-like
complexes, called hSWI/SNF or BAF, are required for full
function of several activators, including the glucocorticoid
receptor [43], estrogen receptor [44], retinoid receptors
[45], C/EBPβ [46], c-Myc [47], heat shock factor [48] and
MyoD [49]. 
Overexpression of dominant-negative versions of either
hBRM or BRG1 leads to similar defects in transcription
in cultured cells, suggesting that they may have similar
functions in vivo [48,49]. Deletion of the mouse Brm gene,
however, leads to a viable animal with only a minimal cell-
cycle phenotype, whereas mice embryos homozygous for a
Brg1 deletion die very early in development prior to
implantation [50,51]. Consistent with these findings, dele-
tion of the gene encoding mSNF5/INI1, a subunit of both
types of SWI/SNF-like complex, also leads to embryonic
lethality prior to implantation [52,53]. Thus, Brm-based
and Brg1-based complexes appear to have distinct roles in
mouse development. The essential role of Brg1 during
early development is reminiscent of the Drosophila brm
gene, which is also essential for oogenesis and early fly
development [54].
In addition to a key role in early development, Brg1-
based, SWI/SNF-like complexes also play an essential role
in a tumor suppressor pathway. Mice heterozygous for
Brg1 or snf5/ini1 deletions are prone to a variety of tumor
types, including glandular epithelial tumors and malignant
rhabdoid tumors [51–53]. Similarly, mutations in human
SNF5/INI1 were found to be causative for an aggressive,
pediatric rhabdoid tumor, and subsequently for a variety
of other types of neoplasm [55,56]. hSWI/SNF complexes
are known to physically interact with the retinoblastoma
protein, cyclin E and BRCA1, which is consistent with
roles for hSWI/SNF in governing cell-cycle control and
DNA damage response [57–59]. In addition, hSWI/SNF
complexes are required for proper cell-cycle regulation of
cyclin A and cyclin E expression, and for cell-cycle pro-
gression at the G1/S and S/G2 boundaries [60,61].
How is ATP hydrolysis used to ‘remodel’ chromatin?
The chromatin remodeling activity of SWI/SNF-like
complexes has been demonstrated by a number of in vitro
assays. The biochemical outcomes of this reaction include:
changes in the rotational path of nucleosomal DNA on the
surface of a histone octamer [7,15]; loss of  approximately
40 basepairs of DNA from remodeled nucleosomes [62];
enhanced accessibility of nucleosomal DNA to transcrip-
tion factors [7,15,63] and restriction enzymes [64]; loss of
supercoils from circular chromatin [15,65]; movements of
histone octamers in cis [65,66] and in trans [66,67]; and
formation of di-nucleosome-like particles [68,69]. How
ATP hydrolysis is coupled to these changes is not yet
clear. Two recent reports [70,71] support the idea that
the energy of ATP hydrolysis is used to drive a change in
the twist of nucleosomal DNA which then generates a
‘remodeled’ state.
In a major breakthrough, Owen-Hughes and colleagues
[71] demonstrated that several ATP-dependent chromatin
remodeling enzymes — ySWI/SNF, xMi-2, recombinant
ISWI and BRG1 — can use the energy of ATP hydrolysis
to generate superhelical torsion in naked DNA or nucleo-
somal substrates. These authors developed a quantitative
assay which uses cleavage by bacteriophage T4 endonu-
clease VII to monitor the ability of alternating adenine-
thymine sequences ([AT]n) to form cruciform structures.
Stable cruciform formation only occurs on negatively
supercoiled DNA, but cruciforms were formed on linear
substrates only after the addition of ATP and a remodel-
ing enzyme, such as ySWI/SNF. Remarkably, ySWI/SNF
and recombinant BRG1 can generate superhelical torsion
even on naked DNA substrates, indicating that a con-
served feature of these enzymes is the ability to use the
energy of ATP hydrolysis to drive changes in DNA twist.
In a complementary study, small circular nucleosomal
arrays were used to investigate whether changes in DNA
topology are actually required for ySWI/SNF to remodel
nucleosomes, as assayed by enhanced restriction enzyme
accessibility [70]. When DNA topology was constrained in
small circular substrates, ySWI/SNF was unable to enhance
nucleosomal DNA accessibility unless a topoisomerase
was added to the reaction. Furthermore, remodeling of
small circular chromatin substrates yielded enhanced
restriction enzyme accessibility without movement of the
histone octamers. This state of enhanced accessibility
required continuous ATP hydrolysis, which indicates that
this remodeled state is unstable and rapidly reverts back
to the normal, occluded state. This result contrasts to the
remodeling of linear arrays or large minichromosomes,
where the ATP-dependent movement of histone octamers
generates persistent changes in DNA accessibility [65].
Together with the results from Owen-Hughes and col-
leagues [71], which showed that cruciform formation also
requires continuous ATP hydrolysis, these data suggest
that a continuous, ATP-dependent change in DNA twist
is the bio-mechanical force that generates a remodeled
nucleosome, and furthermore that ATP-dependent remod-
eling can generate an accessible nucleosomal state even in
the absence of histone octamer movements. 
How does ATP hydrolysis generate changes in DNA
twist? Two models have been proposed [70,71]. In the
first, the ATP-dependent tracking of a remodeling enzyme
along DNA generates torsional stress both in front and
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behind the translocating enzyme [71]. For enzymes which
hydrolyze ATP on nucleosomal substrates, this model also
implies that DNA tracking can also occur on the surface
of the nucleosome itself. An alternative model suggests
that DNA twisting is a result of continuous cycles of
ATP-dependent DNA helix deformation [70]. Such a
mechanism may be similar to how monomeric DNA
helicases use ATP hydrolysis to drive DNA helix destabi-
lization [72]. In the latter case, remodeling enzymes need
not translocate along DNA, but simply bind to the DNA
component of a properly assembled nucleosomal substrate.
Importantly, both of these ‘DNA twisting’ models are con-
sistent with recent studies which indicate that ATP-depen-
dent remodeling enzymes disrupt only the DNA–histone
interactions of nucleosomes; for example, SWI/SNF-like
enzymes do not evict histones from nucleosomal substrates
[62,68,73], nor does remodeling appear to lead to measur-
able changes in histone–histone interfaces [74].
Histone acetyltransferases and transcriptional activation
Histones are the targets for a variety of post-translational
covalent modifications, including phosphorylation,
methylation, ubiquitination and ADP-ribosylation (for a
recent review see [75]). One of the long-standing ‘Holy
Grails’ of the chromatin community was the goal of iden-
tifying a nuclear histone acetyltransferase that directly
contributes to transcriptional regulation. That objective
has now been accomplished many times over in the past
few years, but the initial breakthrough came when Allis
and colleagues discovered [76] that yeast Gcn5p had
intrinsic histone acetyltransferase activity. In previous
genetic studies, GCN5 had been identified as a positive
regulator of transcription [77], and it had been proposed
that Gcn5p might function as an adaptor that bridges
between the general transcription machinery and gene-
specific activators such as Gcn4p or a Gal4–VP16
chimeric activator [78]. But subsequent studies have
shown that Gcn5p facilitates activator function via its
acetyltransferase activity, as mutational inactivation of
this domain eliminates function in vivo [79,80]. Immedi-
ately after these discoveries, numerous other ‘coactiva-
tors’ — for example, TAFII250, SRC-1, ACTR and
CBP/p300 — were found to have intrinsic histone acetyl-
transferase activity that is essential for their transcrip-
tional roles (for a review see [3]).
Remarkably, many inducible genes whose expression
relies on the ySWI/SNF complex also require the function
of the Gcn5p HAT [5]. Furthermore, GCN5 and SWI/SNF
show similar genetic interactions with chromatin compo-
nents [81,82]. More recently, Krebs and colleagues [31]
found that Gcn5p and ySWI/SNF are both required for
expression of a large number of genes in late mitosis (see
above). Thus, in many cases Gcn5p and ySWI/SNF
appear to function in concert to facilitate transcription,
and, as discussed in more detail below, this functional link
between HATs and SWI/SNF-like enzymes appears to
represent a general paradigm for eukaryotic gene regulation.
In addition to Gcn5p, yeast have a second nuclear HAT,
Esa1p, which has been directly linked to activator func-
tion. Esa1p is a member of a family of HATs which is
distinct from the Gcn5p family, but like Gcn5p (see
below), Esa1p has homologs in Drosophila (mof) and
mammals (Tip60). But whereas gcn5 mutants are viable,
ESA1 is an essential gene and its product is required for
cell-cycle progression through G2/M [83–85]. Recently,
Struhl and colleagues [86] have shown that Esa1p is
required for coordinate regulation of a large number of
genes that encode ribosomal proteins. Furthermore,
chromatin immunoprecipitation studies indicate that
Esa1p is recruited to these genes via the Rap1p activator.
Thus, it appears that different HATs have been special-
ized to facilitate expression of distinct sets of genes.
Mammalian cells contain at least two proteins related to
yGCN5: p300/CBP-Associated Factor (PCAF) and human
hGCN5 (GCN512 or PCAF-B in mice) (for a recent
review, see [87]). These proteins contain a carboxy-termi-
nal domain that is 64% identical to yGCN5, and an amino-
terminal domain that facilitates binding to the CBP and
p300 HATs (see below). PCAF and hGCN5 have been
shown to play key roles in transcriptional activation and
are required for the functions of p53-mediated activation
in response to DNA damage and MyoD-mediated activa-
tion during muscle differentiation. Deletion of the mouse
PCAF gene results in a viable animal with no apparent
phenotype; however, mice homozygous for a deletion of
GCN512 die during embryogenesis with a number of
developmental defects, presumably due to an increase in
cell death (apoptosis) [88,89]. These results suggest a key
role for hGCN5 in cellular proliferation and development.
In addition, PCAF and GCN512 may function in c-Myc
and E1A-induced cellular transformation, suggesting a
role for these proteins in carcinogenesis.
CBP and p300 are two highly related HATs found only in
metazoans. CBP was originally identified through its
association with the CREB transcriptional activator and
p300 through its interaction with the adenoviral-
transforming protein E1A. CBP and p300 function as
global regulators of transcriptional activation by several
mechanisms: firstly, by serving as molecular scaffolds to
bridge a variety of activators to other coactivators, such as
SRC-1, PCAF and hSWI/SNF, and the RNA polymerase
II holoenzyme; secondly, by modifying chromatin through
acetylation of nucleosomal histone proteins; and thirdly,
by regulating inherent activities of transcriptional activa-
tors through acetylation (for a recent review, see [90]). In a
similar manner to the functional connection between
ySWI/SNF and Gcn5p, the function of many transcrip-
tional activators, and the expression of several genes,
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appears to require the concerted action of a CBP/p300
HAT and a hSWI/SNF complex. 
Parallels between SWI/SNF-like enzymes and HATs are
also apparent in the developmental roles of CBP/p300 (for
a recent review, see [90]). Mice homozygous for either a
CBP or p300 deletion die early in embryonic development
with multiple developmental and proliferative defects.
Similarly, studies in Drosophila have found that dCBP is
required for multiple developmental processes and is criti-
cal for the function of the Hedgehog and Wingless signal-
ing pathways. Additional studies suggest that the proper
gene-dosage of CBP and p300 is highly critical for devel-
opment. Monoallelic mutations in CBP have been associ-
ated with Rubinstein Taybi Syndrome, a human disorder
resulting in multiple developmental defects and increased
incidence of sporadic cancers. Similarly, mice engineered
with a null mutation in only one allele of CBP develop a
variety of hematological abnormalities and malignancies.
Furthermore, CBP and p300 are involved in somatic
translocations associated with various types of hematologi-
cal malignancy, and their products have been identified as
functional targets of viral oncoproteins, including aden-
ovirus E1A, EBV EBNA2, SV40 large T antigen and
HTLV-1 Tax. In summary, these results strongly suggest
that disruption or deregulation of CBP and p300 activity
may contribute to cancer.
Like the SWI/SNF-like enzymes, HATs also function in
the context of large multisubunit complexes. Biochemical
analyses first showed that yGCN5 is the catalytic subunit
of at least two distinct complexes, the 1 MDa ADA and
2 MDa SAGA complexes [91]. Most studies have focused
on the SAGA complex, as it appears to be the prevalent
form recruited by activators in vivo. In addition to Gcn5p,
subunits of SAGA include several Spt proteins that are
believed to bridge SAGA with the TATA-binding protein
(TBP), an ATM/PI-3-kinase-related protein (Tra1), Ada
proteins and a subset of TBP-associated factors (yTAFIIs)
[91,92]. Subsequent analyses have shown that PCAF and
hGCN5 also function in distinct, but similar complexes,
and each complex contains mammalian homologues of
yAda, ySpt, yTra1 and yTAF proteins [93,94]. The yeast
Esa1 protein also functions in a large, approximately
1 MDa multi-subunit complex containing yTra1 [85],
and mammalian CBP/p300 has been shown to be compo-
nent of RNA polymerase II holoenzyme [95,96]. Thus,
although each of these complexes shares the ability to
acetylate nucleosomal histones, the subunit complexity
suggests an enormous potential for regulation and addi-
tional functions.
How does histone acetylation enhance transcription?
Histone acetylation has been a hallmark of transcription-
ally active genes since the pioneering studies of Allfrey
[97]. Even today, however, it is not yet clear how histone
acetylation facilitates transcription. HATs acetylate lysine
residues located in the amino-terminal domains of the
core histones, H3, H4, H2A and H2B. These amino-
terminal domains extend from the surface of the nucleo-
some, and do not contribute to the histone–histone
interactions that comprise the nucleosome [98]. Further-
more, hyperacetylation of the histone amino-terminal
domains does not disrupt nucleosome assembly, nor does
acetylation lead to dramatic changes in the salt stability of
nucleosomes or their hydrodynamic properties [99]. Acety-
lated nucleosomes do have a slightly lower thermal stabil-
ity, but they contain the same amount of DNA wrapped
onto the surface of the histone octamer [100]. Simply put,
acetylation of nucleosomes is not the silver bullet that
‘kills’ nucleosome structure.
What consequences does acetylation have on chromatin
structure? One clear effect of histone acetylation is the
destabilization of the higher-order folding of chromatin.
In one study, Tse and colleagues [101] measured in vitro
the folding of model nucleosomal arrays that were recon-
stituted with histone octamers containing different levels
of histone acetylation. When the nucleosomal arrays were
incubated in physiological salt conditions, they showed
complex intramolecular and intermolecular folding equi-
libria that appear to mimic a chromosomal level of conden-
sation. These folding equilibria were not disrupted when
the nucleosomal arrays contained an average of two or six
acetyl groups per histone octamer; however, when
octamers contained twelve acetylated lysines, nucleosomal
array folding was abolished. Remarkably, the inability to
fold directly correlated with a large increase in transcrip-
tion initiation and elongation by RNA polymerase III on
the arrays (RNA polymerase II was not tested). These
results suggest that nuclear HATs, such as Gcn5p, PCAF
and CBP/p300, can enhance transcription by acetylating
histones and disrupting the nucleosome–nucleosome
interactions that stabilize chromatin folding.
Recruitment of chromatin remodeling enzymes
An explosion of recent data supports a model in which gene-
specific activators directly recruit SWI/SNF-like enzymes
and HATs to target genes. In the case of ySWI/SNF and
SAGA, each of these purified complexes has been shown to
directly interact with a variety of transcriptional activators,
including yeast GCN4, SWI5, GAL4–VP16 and GAL4–AH
[31,102–104]. Furthermore, in the case of Gcn4p and
Gal4–VP16, these interactions are mediated by the tran-
scriptional activation domain and are sensitive to mutations
that cripple activation function [102–104]. The association
of these remodeling enzymes with activators is functionally
significant, as activators can also recruit SWI/SNF remodel-
ing activity and SAGA’s HAT activity to nucleosomal array
substrates in vitro [104–106], and this recruitment stimulates
transcription by RNA polymerase II from such templates
[102,105,106]. Moreover, recruitment of SWI/SNF and
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SAGA to the HO locus in vivo requires the SWI5 activator
[107,108], and recruitment of SAGA to the HIS3 promoter
requires the Gcn4p activator [109].
The direct recruitment of chromatin remodeling enzymes
by gene-specific activators is not unique to the yeast
enzymes. hSWI/SNF complexes interact with steroidal
and nonsteroidal nuclear hormone receptors [43–45],
c-Myc [47], C/EBPβ [46], MyoD [49] and the zinc finger
domain of EKLF [110]. Similarly, nearly every gene-
specific activator appears to interact with the CBP/p300
HATs, including CREB, p53, MyoD, HNF-4 and Stat-1
[90]. How do activators coordinate interactions with
SWI/SNF-like enzymes, HATs and general transcription
factors? In most cases, it seems that an identical activator
surface is used to recruit different, huge protein com-
plexes. Below we shall describe several recent studies in
which activators have been shown to orchestrate an obliga-
tory sequence of recruitment events, where the enzymatic
activity of one chromatin remodeling enzyme is required
for the subsequent, activator-dependent targeting of a
second type of remodeling enzyme.
Interdependent, sequential pathways — mitotic gene
expression
Two recent studies [107,108] have used chromatin immuno-
precipitation analyses to show that the Swi5p activator
potentiates transcription of the yeast HO gene by sequen-
tially recruiting ySWI/SNF and a Gcn5p HAT complex
during late mitosis. When Swi5p binds in late anaphase to
sites within the far upstream regulatory region of the HO
gene, it immediately recruits the ySWI/SNF complex. ATP-
dependent remodeling by ySWI/SNF is then required for
subsequent telophase recruitment of a Gcn5/Ada2p/Spt20
complex, probably SAGA, which then acetylates approxi-
mately seven nucleosomes upstream of the HO transcription
start sites. The prior recruitment of ySWI/SNF and Gcn5p
is required for the binding of a second gene-specific activa-
tor, called SBF, which then activates HO expression at the
end of G1, presumably by recruiting components of the
general transcription machinery. 
How general is this functional relationship between
ySWI/SNF and Gcn5p? Krebs and colleagues [31] have
shown that the remodeling activity of ySWI/SNF is re-
quired for the recruitment of Gcn5p to a large set of genes
expressed at the end of mitosis, including SIC1, CDC6,
EGT2 and ASH1. In every case, Swi5p is the gene-specific
activator which initiates this sequential chain of events. In
contrast, ySWI/SNF does not affect the interphase recruit-
ment of Gcn5p to many inducible target genes, such as
HIS3, GAL1 and PHO8. Thus, it appears that the
ySWI/SNF-dependent recruitment of Gcn5p is a property
of either the Swi5p activator or mitosis.
To investigate whether mitosis is responsible for this
sequential recruitment pathway, Krebs and colleagues
[31] monitored the recruitment of Gcn5p’s HAT activity
to the inducible GAL1 gene during interphase and during
mitosis. Normally, induction of GAL1 transcription in
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Figure 2
Sequential recruitment of ySWI/SNF and a Gcn5p HAT complex
(SAGA) are required for proper activation of the yeast HO promoter.
(a) The Swi5p activator first binds to the promoter and recruits
ySWI/SNF during anaphase of mitosis. (b) The ATP-dependent
remodeling activity of ySWI/SNF then facilitates recruitment of SAGA
by Swi5p in telophase. (c) This may involve freeing the histone amino-
terminal tails for interactions with and acetylation (Ac) by SAGA.
(d) Together, these two chromatin remodeling enzymes modify the
chromatin structure surrounding the promoter to facilitate the binding
of an additional activator (SBF) in G1 phase. SBF mediates
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asynchronous cells — primarily interphase cells —
requires the Gal4p activator, but not the ySWI/SNF or
Gcn5p remodeling enzymes. Furthermore, Gal4p can
recruit Gcn5p to the GAL1 promoter even in the absence
of ySWI/SNF. But when cells are pre-arrested in late
mitosis, using the cell-cycle mutation cdc15ts, induction of
GAL1 expression becomes completely dependent on both
ySWI/SNF and Gcn5p activities. Furthermore, mitotic
recruitment of Gcn5p HAT activity becomes absolutely
dependent on the remodeling activity of ySWI/SNF.
Thus, by simply changing cell-cycle position — from
interphase to mitosis — transcription of GAL1 becomes
dependent on remodeling enzymes, and expression in late
mitosis requires that Gal4p initiate a novel sequence of
events that leads to transcription. 
How does ATP-dependent chromatin remodeling facilitate
mitotic recruitment of a Gcn5p HAT complex? Gcn5p
HAT complexes such as SAGA can directly interact with
the Swi5p and Gal4p activators, so it seems odd that these
activators need assistance in vivo. In fact, in interphase
cells, Gal4p can recruit Gcn5p in the absence of
ySWI/SNF [31]. One possibility is that the stable recruit-
ment of a Gcn5p HAT complex requires interactions with
both a gene-specific activator and its substrate, the histone
amino-terminal domains. In this model, the histone amino-
terminal domains may be freely accessible during inter-
phase, but the additional condensation of yeast chromatin
during mitosis may occlude the histone amino termini.
Consequently, in the absence of ySWI/SNF, activators
may only briefly recruit Gcn5p HAT complexes during
mitosis, and such transient interactions may not be
detectable by chromatin immunoprecipitation. In this case,
ATP-dependent remodeling may lead to a localized dis-
ruption of mitotic condensation, freeing the histone amino-
terminal domains for interaction with a Gcn5p HAT
complex. Subsequent histone acetylation may then stabi-
lize this unfolded state which facilitates additional events
leading to transcription (Figure 2). 
Two simple models might explain how ATP-dependent
remodeling can disrupt the folding of mitotic chromatin.
First, the folding of nucleosomal arrays requires nucleo-
some–nucleosome interactions that are mediated by the
histone amino-terminal domains. Given that the histone
amino-terminal domains interact with the adjacent gyres
of DNA as they protrude from the nucleosome [98],
ATP-dependent twisting or rotation of nucleosomal
DNA would lead to a major rearrangement of these
histone domains, disrupting their roles in mitotic con-
densation. Alternatively, non-histone proteins may bind
the histone amino-terminal domains during mitosis and
these interactions may stabilize mitotic condensation.
Thus, in this model, the ATP-dependent twisting of
nucleosomal DNA may remove or destabilize the
binding of such proteins. 
Several in vitro studies have investigated the functional
synergies between ATP-dependent remodeling enzymes
and HATs. Ito and colleagues [111] have reconstructed an
ATP-dependent recruitment of HAT activity in vitro,
using nucleosomal array templates assembled in the
presence of the NAP1 histone chaperone protein and the
ATP-dependent remodeling enzyme dACF. In this
in vitro system, ATP-dependent remodeling by dACF in
the presence of an activator, Gal4–VP16, was required for
the subsequent acetylation of the array by the p300 HAT.
Thus, these data appear similar to the mitotic series of
events that occur on yeast genes in vivo. But Ikeda and
colleagues [105,106] found that Gcn5p-containing HAT
complexes can acetylate nucleosomal arrays and stimulate
transcription in the absence of prior ATP-dependent
remodeling. In this case the arrays were assembled from
only histones and DNA. These results are more consis-
tent with how HATs are recruited to yeast genes during
interphase. 
Why does histone acetylation rely on ATP-dependent
remodeling in one in vitro system but not in another? One
possibility is that the HAT activity of p300 per se will
always require prior ATP-dependent remodeling. This is
clearly not the case, as Dilworth and colleagues [45] have
shown that p300/CBP can acetylate nucleosomal arrays in
the absence of ATP-dependent remodeling when arrays
are assembled and then purified from a Drosophila embryo
extract system. Alternatively, the requirement for ATP-
dependent remodeling may be due to the presence of the
NAP1 histone chaperone. NAP1 can bind to all four core
histones in vitro, and it can block the ability of p300 to
acetylate these free histone substrates. Furthermore, it is
known that some NAP1 remains bound to nucleosomes
following their deposition, and thus the nucleosome-
bound NAP1 may also inhibit p300. In this view, ATP-
dependent remodeling by dACF may destabilize the
binding of NAP1, allowing p300 access to the histone
amino-terminal domains. Similarly, NAP1 counterparts may
function in vivo during mitosis, where they stabilize the
higher-order folding of chromatin and shield the histone
amino-terminal domains from interactions with HATs.
Interdependent pathways — the IFN-β enhanceosome
Whereas ATP-dependent remodeling is required for the
subsequent recruitment of HATs during yeast mitosis,
Agalioti and colleagues [112] have recently reported that
the reverse is true during transcriptional induction of the
mammalian IFN-β gene — HAT activity is required for
subsequent recruitment of a SWI/SNF-like enzyme.
Regulation of IFN-β transcription relies on a virus-inducible
enhancer element that contains binding sites for three dis-
tinct gene-specific activators: NF-κB, ATF-2/c-Jun and
IRFs. Activation of these factors in response to viral infec-
tion leads to their cooperative binding with the architec-
tural HMG I(Y) protein to form the IFN-β ‘enhanceosome’.
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HMG I(Y) organizes the enhanceosome into a folded
structure that optimally interacts with components of the
transcription machinery, such as the CBP/RNA poly-
merase II holoenzyme complex. 
The IFN-β enhancer element is located between two
positioned nucleosomes, both in vivo and after in vitro
reconstitution with purified components (Figure 3) [112].
Thus, assembly of the enhanceosome is not impeded
by nucleosomes, whereas one nucleosome is positioned
adjacent to the TATA box and occludes the start site of
transcription. This proximal nucleosome is disrupted
in vivo following enhanceosome activation. Using chromatin
immunoprecipitations, Agalioti and colleagues [112] inves-
tigated the temporal sequence of events that lead to
nucleosome remodeling and IFN-β transcription. HeLa
cells were infected with Sendai virus, and at varying times
post-infection, cells were treated with formaldehyde to
crosslink proteins to DNA. The recruitment of factors to
the IFN-β promoter and enhancer regions was then ana-
lyzed after immunoprecipitation with antibodies directed
against NF-κB, hGCN5, TBP, BRG1, RNA polymerase II,
TBP, TAFII250 and acetylated histone H4. 
Following two hours of viral infection, NF-κB is one of
the first factors recruited to the enhancer, and it likely
serves as a marker for enhanceosome assembly. Targeting
of hGCN5 by the enhanceosome is first detected
three hours after infection, and recruitment of hGCN5
occurs concomitantly with acetylation of histone H4 at the
IFN-β locus. Association of CBP and RNA polymerase II
follows similar kinetics to hGCN5, as they arrive at the
promoter four hours post infection, but CBP/RNA poly-
merase II remains bound to the IFN-β locus for a much
longer time-period. The key recruitment event appears to
be the arrival of hSWI/SNF complex, which associates
with the IFN-β locus six hours post infection. Concomi-
tant with the binding of hSWI/SNF, an NcoI site within
the promoter-bound nucleosome becomes accessible, TBP
and TAFII250 associate with the promoter and the first
IFN-β transcripts are detected. Thus, these in vivo studies
are consistent with the temporally separated, sequential
recruitment for NF-κB, hGCN5, CBP/RNA polymerase
II, hSWI/SNF and TFIID (Figure 3).
Whereas in yeast one can simply use mutants to ask
questions regarding interdependence (see [107,108]),
Agalioti and colleagues [112] used a mammalian in vitro
transcription system to demonstrate that many of the
recruitment steps that lead to IFN-β transcription are
interdependent. IFN-β promoter fragments were reconsti-
tuted into nucleosomes and then immobilized on strepta-
vidin beads. When these immobilized templates were
incubated in a HeLa nuclear extract, and washed exten-
sively to remove unbound proteins, western blotting
demonstrated that CBP, RNA polymerase II, hSWI/SNF,
CBP and TFIID were all recruited in an enhanceosome-
dependent fashion. If the nucleosomal templates were
pre-acetylated using recombinant hGCN5 or p300, approx-
imately five-fold more hSWI/SNF was recruited to the
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Sequential recruitment of a Gcn5p HAT complex and SWI/SNF is
critical for virus-induced activation of the IFN-β promoter. (a) Following
virus infection, several transcriptional activators assemble an
‘enhanceosome’ on the IFN-β enhancer and (b) recruit a Gcn5p
complex which then acetylates histone amino-terminal domains (Ac) in
neighboring nucleosomes. (c) The CBP/RNA polymerase II
holoenzyme complex is then recruited by the enhanceosome.
(d) Finally, SWI/SNF is recruited, presumably through interactions with
acetylated histone amino-terminal tails (acetylation enhances SWI/SNF
recruitment) and CBP, and (e) chromatin remodeling activity facilitates
binding of TFIID and assembly of a functional pre-initiation complex (PIC).
IFN-β promoter, whereas recruitment of CBP/RNA poly-
merase II was not stimulated. Thus, histone acetylation
governs efficient enhanceosome-dependent recruitment
of hSWI/SNF. Furthermore, the increased recruitment of
hSWI/SNF was also associated with an enhanced restric-
tion enzyme accessibility of the nucleosomal promoter —
‘remodeling’ — and consequently more TFIID was
bound to the template.
In a complementary set of experiments, specific antibod-
ies were used to deplete individual proteins from the
HeLa nuclear extract prior to incubation with the nucleo-
somal IFN-β template. When the CBP/RNA polymerase
II holoenzyme complex was immuno-depleted from the
extract, the hSWI/SNF complex was unable to associate
with the promoter, even though the enhanceosome (and
its gene-specific activators) was intact. Furthermore,
CBP, and not the RNA polymerase II holoenzyme, was
responsible for hSWI/SNF recruitment, as immuno-deple-
tion of just RNA polymerase II holoenzyme did not dimin-
ish the association of hSWI/SNF. Thus, recruitment of
hSWI/SNF to the IFN-β template requires the enhanceo-
some, histone acetylation and CBP (see Figure 3).
How does histone acetylation enhance the recruitment
of hSWI/SNF complex? It seems unlikely that histone
acetylation disrupts the folding of these chromatin sub-
strates, as the IFN-β templates are composed of only two
nucleosomes. Furthermore, HAT activity does not stimu-
late hSWI/SNF recruitment by acetylating a non-histone
component, such as an enhanceosome factor, as stimula-
tion of hSWI/SNF recruitment was observed even when
array templates were pre-acetylated prior to enhanceo-
some formation. The simplest possibility is that the
binding of hSWI/SNF to acetylated histone amino-termi-
nal domains stabilizes an inherently weak interaction with
CBP (Figure 3). The BRG1 ATPase subunit does contain
a bromodomain, which may mediate this interaction with
an acetylated histone amino-terminal domain (reviewed in
[22]). This model may also explain why histone acetyla-
tion enhances the in vitro recruitment of hSWI/SNF by
the RAR/RXR heterodimer [45]. One prediction of this
model is that an activator that has a much higher affinity
for hSWI/SNF might be able to bypass the requirement
for histone acetylation. Consistent with this possibility,
recruitment of hSWI/SNF does not require histone acety-
lation if a promoter contains multiple copies of the NF-κB
binding site [112].
Partner exchange – knowing when to let go
At present there are only a few examples where the
interdependent recruitment of chromatin remodeling
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The bromodomain may facilitate the exchange of chromatin remodeling
complexes from activators to nucleosomal substrates. (a) An activator
first recruits the Gcn5p HAT complex, which (b) acetylates
neighboring histones. (c) The bromodomain of Gcn5p allows transfer
of the enzyme from the activator to the acetylated histone
amino-terminal domains. This exchange allows for subsequent
recruitment of SWI/SNF complex. (d) In the absence of a
bromodomain (∆bromoHAT), the HAT is unable to release from the
activator, and subsequent recruitment of SWI/SNF is blocked.
enzymes has been demonstrated either in vivo or in vitro
(discussed above). In contrast, there are numerous cases
where SWI/SNF-like enzymes and HATs appear to be
recruited independently to target genes, and both activi-
ties are absolutely essential for transcription. For example,
transcriptional induction of the yeast HIS3 gene requires
both ySWI/SNF and Gcn5p, but the Gcn4p activator can
recruit each of these enzymes in the absence of the other
([113]; see also [31]). Furthermore, mutational analysis of
Gcn4p suggests that the same activation domain surface is
used by Gcn4p to recruit the approximately 2 MDa
ySWI/SNF and SAGA complexes [103]. 
Once an activator such as Gcn4p has recruited a
SWI/SNF-like enzyme or HAT to a target gene, what
controls the release of that enzyme so that the next target
can be sequestered and brought to the promoter region?
Or is the rate of partner exchanges simply determined by
the dissociation constant (Kd) for each target? A recent
study by Syntichaki and colleagues [113] suggests the
intriguing possibility that chromatin-remodeling enzymes
are actively released from an activator before another
target protein can be sequestered. These authors investi-
gated whether the bromodomain of the Gcn5p HAT plays
a role in HIS3 transcription in yeast. Consistent with
previous results, disruption of the Gcn5p bromodomain
(Gcn5∆bromo) lowered HIS3 expression to the same
degree as a deletion of the GCN5 gene. The Gcn5∆bromo
protein was still recruited to the HIS3 locus by Gcn4p,
however, and it was fully competent for acetylation of
HIS3 nucleosomes. So even though the Gcn5∆bromo
protein was unable to support HIS3 transcription, it appears
to be fully functional. Surprisingly, when Gcn5∆bromo was
expressed, ySWI/SNF was no longer recruited to HIS3.
This seems odd, as ySWI/SNF is recruited to HIS3 in the
complete absence of Gcn5p. 
How can Gcn5∆bromo block the ability of Gcn4p to
recruit ySWI/SNF? Previous studies have shown that the
Gcn5 and PCAF bromodomains mediate binding to acety-
lated histone amino-terminal domains [114,115]. Syn-
tichaki and colleagues [113] suggested that the role of the
Gcn5p bromodomain is to shield ySWI/SNF from acety-
lated nucleosomes, which may interfere with recruitment.
We propose an alternative model, in which the bromod-
omain is required for the exchange of Gcn5p from the acti-
vator (Gcn4p) to the acetylated histone amino-terminal
domains (Figure 4).
Essentially, the bromodomain would functionally couple
recruitment with HAT activity — once the HAT has
performed its acetylation role, it is released from the
activator to allow for recruitment of an additional chro-
matin remodeling complex or a general transcription
factor. Similarly, if the Gcn4p activator first recruits
ySWI/SNF, then the bromodomain of Swi2p/Snf2p [116]
could facilitate the transfer of ySWI/SNF to histone
amino-terminal tails, allowing for subsequent recruitment
of Gcn5p. Of course, in the case of ySWI/SNF, the high
affinity of this enzyme for nonspecific DNA might also
facilitate partner exchange [117]. This model suggests
that, although targets for a transcriptional activator may
sometimes appear to be recruited in an independent
fashion, there could still be an underlying coordination of
these events.
Summary
Several new paradigms have recently emerged in the
regulation of eukaryotic gene expression. First, tran-
scription from chromatin templates in vivo and in vitro
often requires two types of chromatin remodeling
enzymes that function in concert — a SWI/SNF-like
ATP-dependent chromatin remodeling enzyme and a
HAT. Second, recruitment of different chromatin remod-
eling enzymes can be interdependent and rely on each
other’s enzymatic activities. And third, histone-binding
domains, like the bromodomain, can contribute to tran-
scriptional control by influencing subsequent activator-
dependent recruitment events. But many questions
remain unanswered. How does histone acetylation facili-
tate transcription? What is the composition of mitotic
chromatin? And how do ATP-dependent remodeling
enzymes function in this environment? What does the
combination of histone acetylation (and other histone
posttranslational modifications) and ATP-dependent
remodeling do to chromatin structure? Future studies will
undoubtedly focus on unraveling these mysteries.
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